Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA2R0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,153
Award facts
- Contract value 100% obligated
- $55,152.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $55,152.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. The contract was awarded on January 15, 2026, with an ultimate completion date of January 16, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order was awarded on a competitive, non-set-aside basis and represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The parent IDC, valued at up to $999,999,999.00 and extending through December 31, 2031, serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp functions as a critical vendor in the federal medical supply chain, delivering diabetes medications and other pharmaceutical products to support Defense Health Agency operations and broader military healthcare requirements. The firm fixed-price delivery order structure and the company's established capability within the DLA Troop Support Medical contract vehicle demonstrate AmerisourceBergen's role as a primary pharmaceutical distributor for government healthcare systems serving military personnel and veterans.
Quick answers
Who was awarded contract SPE2DR26FA2R0?
SPE2DR26FA2R0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FA2R0 worth?
The government has obligated $55,153 on SPE2DR26FA2R0.
Is contract SPE2DR26FA2R0 an order under another contract?
Yes. SPE2DR26FA2R0 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA2R0 competed?
The extent of competition for SPE2DR26FA2R0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award